“I love it when my cervical cancer is discunted!”—23-year-old female
An email inviting young women to participate in a trial of the cervical cancer vaccine Gardasil has been circulated with an unfortunate spelling mistake in the subject line.
The email with the subject line “Discunted Cervical Cancer (Gardasil) offer to trial female participants 21-26 years”, sent by the Immunisation Advisory Centre (IMAC) at the University of Auckland, was received by an Auckland womens’ group.
IMAC Research is calling for women 14- to 26-years old, who have not received a dose of Gardasil, to participate in a study to explore how to make injections more comfortable.
Women aged between 14 and 20 can get the vaccine for free, while those over 20 years who participate in the trial are offered a “discunted” rate of “only $50+ GST for the first dose and $99+ GST for the second two doses”.
Well you don’t want your health to be ovary-priced, do you?